Hidden and Understaffed: Exploring Canadian Medical Laboratory Technologists' Pandemic Stressors and Lessons Learned. [PDF]
Dignos PN +6 more
europepmc +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Self-reported continuing professional development needs of medical laboratory professionals in Ghana. [PDF]
Essuman MA +10 more
europepmc +1 more source
Internal Quality Control in Medical Laboratories: Westgard and the Others [PDF]
Marco Pradella
openalex +1 more source
Integrating pre-clinical skills training in skills laboratory and primary health care centers to prepare medical students for their clerkships [PDF]
Doni Widyandana
openalex +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
What would the medical students like to know in laboratory medicine?
Laboratory medicine is an important subject in medical education. According to the principles of student-based teaching, an evaluation of the students' perception towards the taught subjects is important.
V Wiwanitkit
doaj
Taking the train of digital health and artificial intelligence to improve medical laboratory service in Africa: Key considerations. [PDF]
Erasmus R, Ondoa P.
europepmc +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Development and validation of a questionnaire for laboratory medicine knowledge and attitudes in clinical medical interns [PDF]
Yonggang Yang +4 more
openalex +1 more source

